Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in United Therapeutics Corporation.

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Buy	2.1M	2.1M	+18K	€278.10–€365.40
2024-Q4	Sell	2.2M	2.1M	-66K	€316.10–€387.10
2024-Q3	Sell	2.2M	2.2M	-19K	€289.10–€329.50
2024-Q2	Buy	2.2M	2.2M	+23K	€210.80–€298.90
2024-Q1	Sell	2.2M	2.2M	-19K	€195.30–€227.80
2023-Q4	Sell	2.3M	2.2M	-80K	€193.50–€233.60
2023-Q3	Buy	2.2M	2.3M	+63K	€192.80–€223.10
2023-Q2	Sell	2.2M	2.2M	-40K	€189.80–€212.00
2023-Q1	Sell	2.3M	2.2M	-117K	€196.65–€260.40
2022-Q4	Sell	2.6M	2.3M	-206K	€210.30–€271.30
2022-Q3	Sell	2.8M	2.6M	-243K	€207.30–€240.25
2022-Q2	Buy	2.8M	2.8M	+28K	€163.77–€229.54
2022-Q1	Sell	2.9M	2.8M	-152K	€148.00–€188.00
2021-Q4	Sell	3M	2.9M	-111K	€156.00–€189.00
2021-Q3	Sell	3.1M	3M	-82K	€151.00–€180.00
2021-Q2	Sell	3.2M	3.1M	-97K	€140.00–€175.00
2021-Q1	Sell	3.6M	3.2M	-400K	€120.00–€144.00
2020-Q4	Sell	3.7M	3.6M	-102K	€87.00–€123.00
2020-Q3	Sell	3.7M	3.7M	-18K	€84.50–€108.00
2020-Q2	Buy	3.6M	3.7M	+137K	€85.00–€111.00
2020-Q1	Buy	3.5M	3.6M	+46K	€71.00–€99.50
2019-Q4	Buy	3.2M	3.5M	+332K	€71.00–€85.50
2019-Q3	Buy	3M	3.2M	+171K	€66.24–€78.89
2019-Q2	Buy	2.2M	3M	+799K	€66.51–€107.38
2019-Q1	Buy	2.2M	2.2M	+45K	€93.77–€111.64
2018-Q4	Buy	1.9M	2.2M	+253K	€89.46–€110.50
2018-Q3	Buy	1.5M	1.9M	+410K	€97.29–€112.74
2018-Q1	Buy	1.5M	1.5M	+72K	€86.91–€125.12
2017-Q4	Buy	1.3M	1.5M	+189K	€100.11–€126.44
2017-Q3	Buy	838K	1.3M	+435K	€96.19–€117.76
2017-Q2	Buy	506K	838K	+331K	€105.62–€119.60
2017-Q1	Buy	421K	506K	+85K	€123.29–€158.72
2016-Q4	Buy	390K	421K	+31K
2016-Q3	Sell	404K	390K	-14K
2016-Q2	Sell	475K	404K	-70K
2016-Q1	Sell	552K	475K	-78K
2015-Q4	Sell	867K	552K	-315K
2015-Q3	Buy	812K	867K	+55K
2015-Q2	Buy	447K	812K	+365K
2015-Q1	Buy	185K	447K	+261K
2014-Q4	Buy	2.4K	185K	+183K
2014-Q3	Sell	252K	2.4K	-250K
2014-Q2	Sell	288K	252K	-35K
2014-Q1	Buy	224K	288K	+64K
2013-Q4	Sell	441K	224K	-217K
2013-Q3	Sell	590K	441K	-150K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors